Skip to Main Content

Paper Details

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
Blood
30
2020
AEL, AEL leukemic, AEL leukemic cells, AEL samples, AML-associated oncogenes, Acute erythroleukemia, DNMT3A, ERG, GATA1, GATA1-binding sites, Human, IDH2, SKI, TET2, TP53, acute myeloid leukemia, cell population, epigenetic regulator, erythroid phenotype, erythroid vs myeloid transcriptome, erythroid, mixed erythroid/myeloid, or other malignancies, erythroleukemia, hematologic malignancy, hematopoietic stem or progenitor cells, murine, murine erythroid progenitors, myelodysplastic syndrome, non-M6 AML, patients
Author NameAffiliation
Frederik Otzen BaggerUniversity Children's Hospital Beider Basel (UKBB)
Frederik Otzen BaggerUniversity of Basel
Frederik Otzen BaggerCenter for Genomic Medicine, Copenhagen University Hospital
Frederik Otzen Bagger
Jean-Baptiste MicolINSERM, Universite Paris Diderot
Charles G MullighanSt. Jude Children's Research Hospital
Charles G MullighanSt. Jude Children's Research Hospital
Daniel Birnbaum
Daniel BirnbaumCentre National de la Recherche Scientifique (CNRS)/INSERM/Institut Paoli Calmettes/Aix-Marseille Universite
  • 1 - 9

Datasets

Release 1.2